用于缺血性心力衰竭的骨髓源细胞的临床试验。是时候继续前进了吗？TIME、SWISS-AMI、CELLWAVE、POSEIDON和C-CURE。 - Suppr

Suppr

超能文献

Clinical trials of bone marrow derived cells for ischemic heart failure. Time to move on? TIME, SWISS-AMI, CELLWAVE, POSEIDON and C-CURE.

作者信息

Raynaud Christophe M, Yacoub Magdi H

机构信息

Qatar Cardiovascular Research Center, Doha, Qatar.

出版信息

Glob Cardiol Sci Pract. 2013 Nov 1;2013(3):207-11. doi: 10.5339/gcsp.2013.28. eCollection 2013.

DOI:10.5339/gcsp.2013.28

PMID:24689022

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3963753/

Abstract

摘要

相似文献

Clinical trials of bone marrow derived cells for ischemic heart failure. Time to move on? TIME, SWISS-AMI, CELLWAVE, POSEIDON and C-CURE.

Glob Cardiol Sci Pract. 2013 Nov 1;2013(3):207-11. doi: 10.5339/gcsp.2013.28. eCollection 2013.

The Effect of Transendocardial Stem Cell Injection on Erectile Function in Men With Cardiomyopathy: Results From the TRIDENT, POSEIDON, and TAC-HFT Trials.

J Sex Med. 2020 Apr;17(4):695-701. doi: 10.1016/j.jsxm.2020.01.003. Epub 2020 Feb 12.

Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial.

JAMA. 2013 Apr 17;309(15):1622-31. doi: 10.1001/jama.2013.3527.

Effectiveness of Stem Cell Therapies in Improving Clinical Outcomes in Patients With Heart Failure.

Cureus. 2021 Aug 16;13(8):e17236. doi: 10.7759/cureus.17236. eCollection 2021 Aug.

Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data.

Circ Res. 2015 Apr 10;116(8):1346-60. doi: 10.1161/CIRCRESAHA.116.304346. Epub 2015 Feb 19.

Acute myocardial infarction activates progenitor cells and increases Wnt signalling in the bone marrow.

Eur Heart J. 2012 Aug;33(15):1911-9. doi: 10.1093/eurheartj/ehr388. Epub 2011 Dec 15.

[Correlation of changes in circulating bone marrow stem cells in pregnant rabbits after acute myocardial infarction with serum estradiol].

Nan Fang Yi Ke Da Xue Xue Bao. 2006 Feb;26(2):237-9.

Bone-marrow-derived progenitor cell therapy in need of proof of concept: design of the REPAIR-AMI trial.

Nat Clin Pract Cardiovasc Med. 2006 Mar;3 Suppl 1:S23-8. doi: 10.1038/ncpcardio0441.

Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics.

J Am Coll Cardiol. 2013 Jun 11;61(23):2329-38. doi: 10.1016/j.jacc.2013.02.071. Epub 2013 Apr 10.

Effects of Transendocardial Stem Cell Injection on Ventricular Proarrhythmia in Patients with Ischemic Cardiomyopathy: Results from the POSEIDON and TAC-HFT Trials.

Stem Cells Transl Med. 2017 May;6(5):1366-1372. doi: 10.1002/sctm.16-0328. Epub 2017 Mar 2.

引用本文的文献

Alginate for cardiac regeneration: From seaweed to clinical trials.

Glob Cardiol Sci Pract. 2016 Mar 31;2016(1):e201604. doi: 10.21542/gcsp.2016.4.

Human adipose stem cell and ASC-derived cardiac progenitor cellular therapy improves outcomes in a murine model of myocardial infarction.

Stem Cells Cloning. 2015 Oct 29;8:135-48. doi: 10.2147/SCCAA.S86925. eCollection 2015.

Reprogramming for cardiac regeneration.

Glob Cardiol Sci Pract. 2014 Oct 16;2014(3):309-29. doi: 10.5339/gcsp.2014.44. eCollection 2014.

Human Umbilical Cord-Derived Mesenchymal Stem Cells Utilize Activin-A to Suppress Interferon-γ Production by Natural Killer Cells.

Front Immunol. 2014 Dec 29;5:662. doi: 10.3389/fimmu.2014.00662. eCollection 2014.

本文引用的文献

CADUCEUS, SCIPIO, ALCADIA: Cell therapy trials using cardiac-derived cells for patients with post myocardial infarction LV dysfunction, still evolving.

Glob Cardiol Sci Pract. 2013 Nov 1;2013(1):5-8. doi: 10.5339/gcsp.2013.3. eCollection 2013.

Endothelial cells provide a niche for placental hematopoietic stem/progenitor cell expansion through broad transcriptomic modification.

Stem Cell Res. 2013 Nov;11(3):1074-90. doi: 10.1016/j.scr.2013.07.010. Epub 2013 Aug 9.

The Necessity of a Systematic Approach for the Use of MSCs in the Clinical Setting.

Stem Cells Int. 2013;2013:892340. doi: 10.1155/2013/892340. Epub 2013 Jun 23.

Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function.

Circulation. 2013 May 14;127(19):1968-79. doi: 10.1161/CIRCULATIONAHA.112.001035. Epub 2013 Apr 17.

Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial.

JAMA. 2013 Apr 17;309(15):1622-31. doi: 10.1001/jama.2013.3527.

Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics.

J Am Coll Cardiol. 2013 Jun 11;61(23):2329-38. doi: 10.1016/j.jacc.2013.02.071. Epub 2013 Apr 10.

Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial.

JAMA. 2012 Dec 12;308(22):2380-9. doi: 10.1001/jama.2012.28726.

Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.

JAMA. 2012 Dec 12;308(22):2369-79. doi: 10.1001/jama.2012.25321.

Development of a vascular niche platform for expansion of repopulating human cord blood stem and progenitor cells.

Blood. 2012 Aug 9;120(6):1344-7. doi: 10.1182/blood-2011-12-398115. Epub 2012 Jun 18.

Stem cell treatment for acute myocardial infarction.

Cochrane Database Syst Rev. 2012 Feb 15(2):CD006536. doi: 10.1002/14651858.CD006536.pub3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验